✦ LIBER ✦

Golimumab in psoriatic arthritis: One-year clinical efficacy, radiographic, and safety results from a phase III, randomized, placebo-controlled trial

✍ Scribed by Arthur Kavanaugh; Désirée van der Heijde; Iain B. McInnes; Philip Mease; Gerald G. Krueger; Dafna D. Gladman; Juan Gómez-Reino; Kim Papp; Anna Baratelle; Weichun Xu; Surekha Mudivarthy; Michael Mack; Mahboob U. Rahman; Zhenhua Xu; Julie Zrubek; Anna Beutler

Book ID: 112002728
Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 231 KB
Volume: 64
Category: Article
ISSN: 0004-3591
DOI: 10.1002/art.34436

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and safety of golimumab in pati

Efficacy and safety of golimumab in patients with ankylosing spondylitis: Results of a randomized, double-blind, placebo-controlled, phase III trial

✍ Robert D. Inman; John C. Davis Jr.; Désirée Van Der Heijde; Laura Diekman; Joach 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 168 KB 👁 2 views

## Abstract ## Objective To evaluate the efficacy and safety of golimumab in patients with ankylosing spondylitis (AS) in the GO‐RAISE study. ## Methods Patients with active AS, a Bath AS Disease Activity Index (BASDAI) score ≥4, and a back pain score of ≥4 were randomly assigned in a 1.8:1.8:1

Efficacy and safety of leflunomide in th

Efficacy and safety of leflunomide in the treatment of psoriatic arthritis and psoriasis: A multinational, double-blind, randomized, placebo-controlled clinical trial

✍ J. Peter Kaltwasser; Peter Nash; Dafna Gladman; Cheryl F. Rosen; Frank Behrens; 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 157 KB 👁 2 views

## Abstract ## Objective Current treatment options for psoriatic arthritis (PsA) are limited. Leflunomide, an oral pyrimidine synthesis inhibitor, is highly effective in the treatment of rheumatoid arthritis, and small studies have suggested similar efficacy in PsA. We undertook this double‐blind,

Efficacy and safety of dexanabinol in se

Efficacy and safety of dexanabinol in severe traumatic brain injury: results of a phase III randomised, placebo-controlled, clinical trial

✍ Andrew IR Maas; Gordon Murray; Herbert Henney III; Nadim Kassem; Valerie Legrand 📂 Article 📅 2006 🏛 The Lancet 🌐 English ⚖ 111 KB

Infliximab inhibits progression of radio

Infliximab inhibits progression of radiographic damage in patients with active psoriatic arthritis through one year of treatment: Results from the induction and maintenance psoriatic arthritis clinical trial 2

✍ D. van der Heijde; A. Kavanaugh; D. D. Gladman; C. Antoni; G. G. Krueger; C. Guz 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 121 KB 👁 2 views

Efficacy and safety results from a phase

Efficacy and safety results from a phase III, randomized controlled trial comparing the safety and efficacy of briakinumab with etanercept and placebo in patients with moderate to severe chronic plaque psoriasis

✍ B.E. Strober; J.J. Crowley; P.S. Yamauchi; M. Olds; D.A. Williams 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 293 KB

Golimumab, a new human tumor necrosis fa

Golimumab, a new human tumor necrosis factor α antibody, administered every four weeks as a subcutaneous injection in psoriatic arthritis: Twenty-four–week efficacy and safety results of a randomized, placebo-controlled study

✍ Arthur Kavanaugh; Iain McInnes; Philip Mease; Gerald G. Krueger; Dafna Gladman; 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 124 KB 👁 1 views